Category Archives: Defective Drugs

Follow our blog to learn more about current lawsuits involving defective drugs. For more information on filing a product liability lawsuit, call our law offices.

First Taxotere Bellwether Trial Slated to Begin September 2019

The first bellwether trial in the Taxotere litigation has been scheduled for September 2019—just one of more than 12,000 liability lawsuits claiming that the chemotherapy drug’s manufacturer, Sanofi-Aventis, failed to adequately warn patients that permanent hair loss may result from taking the drug. U.S. District Judge Jane Triche Milazzo in the Eastern District of Louisiana . . Read More »

Bellwether Trials in Taxotere Lawsuit to Begin May 2019

On June 13th, the federal court overseeing thousands of Taxotere lawsuits ordered that bellwether trials will begin in May 2019. Taxotere (docetaxel) is a chemotherapy drug manufactured by Sanofi-Aventis. Recently, over 8,700 lawsuits have been filed alleging that alopecia (hair loss) caused by this drug is far more likely to be permanent compared to equally-effective alternative medications. . . Read More »